Quantum Computing in Healthcare Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Component, By Technology, By Application, By Region & Competition, 2021-2031F

The Global Quantum Computing in Healthcare Market is projected to expand from USD 138.94 Billion in 2025 to USD 1173.69 Billion by 2031, achieving a CAGR of 42.71%. This field involves applying quantum mechanical principles, specifically entanglement and superposition, to process intricate biological and chemical data at speeds exponentially exceeding those of classical supercomputers. The market is primarily driven by the urgent need to expedite pharmaceutical drug discovery pipelines and the growing demand for high-precision genomic analysis to facilitate personalized medicine. These requirements necessitate advanced simulation capabilities capable of modeling molecular interactions with an accuracy that traditional computational methods cannot match, thereby significantly lowering research and development costs.

However, the market faces substantial obstacles regarding technical maturity, particularly the difficulty of maintaining qubit coherence and managing error rates within noisy environments. This hardware instability currently restricts the scalability of practical applications, necessitating a cautious integration strategy. The experimental nature of the technology is highlighted by the Pistoia Alliance, which reported that in 2025, approximately 18% of life sciences organizations anticipated utilizing quantum computing in their laboratories, a figure that underscores the engineering hurdles that persist despite the technology's transformative potential.

Market Driver

The most significant driver for the Global Quantum Computing in Healthcare Market is the ability to accelerate molecular simulation and drug discovery. Traditional computational methods frequently fail to model the complexity of molecular interactions with the necessary precision, creating bottlenecks in pharmaceutical R&D. Quantum algorithms overcome this by simulating chemical processes at the atomic level, significantly reducing both the time and capital required to identify viable drug candidates. This potential has prompted major industry players to allocate substantial resources; for instance, according to a May 2024 press release titled 'Novo Holdings Commits DKK 1.4 Billion to Quantum Technology Start-Up Ecosystem,' Novo Holdings allocated EUR 188 million specifically to advance quantum technologies with direct life sciences applications.

A second critical factor propelling market growth is the rise in public and private investments, which provide the essential infrastructure for these experimental technologies to mature. Governments and private entities are establishing dedicated hubs to address hardware instability and scale practical use cases in diagnostics and treatment. For example, the UK Government announcement 'Government invests £100m in five quantum research hubs' in July 2024 detailed a £100 million investment to establish new centers, including those focused on medical sensing and healthcare. Similarly, in December 2024, Wellcome Leap's Quantum for Bio program continued its momentum by advancing projects eligible for up to $40 million in research funding to demonstrate quantum advantage in human health.

Market Challenge

The primary impediment to the Global Quantum Computing in Healthcare Market is the lack of technical maturity concerning hardware stability, specifically the challenge of managing high error rates and maintaining qubit coherence. In the genomic and pharmaceutical sectors, where molecular simulations demand absolute precision for patient safety and drug efficacy, current "Noisy Intermediate-Scale Quantum" (NISQ) processors often fail to maintain the state fidelity required for complex calculations. This instability makes quantum systems unreliable for regulatory-grade data processing, forcing life sciences organizations to restrict their engagement to experimental pilot programs rather than integrating the technology into critical R&D workflows.

Compounding this challenge is a severe shortage of the specialized engineering talent needed to solve these intricate physics problems and accelerate the development of fault-tolerant hardware. According to the Quantum Economic Development Consortium (QED-C), the global quantum industry faced a critical workforce gap in 2025, with more than 7,400 unfilled technical job openings. This scarcity of skilled human capital directly slows the engineering breakthroughs required to reduce error rates, thereby delaying the commercial viability of quantum solutions for healthcare applications and stifling overall market expansion.

Market Trends

The integration of Quantum Computing with Artificial Intelligence and Machine Learning is reshaping the market by transcending the computational limits of classical AI in molecular simulation. This trend involves using large quantitative models and quantum-inspired algorithms to generate precise training data for AI, enabling the modeling of complex biological systems with unprecedented accuracy. By combining physics-based quantum simulations with accelerated computing, researchers can simulate enzyme active sites and catalysts that were previously impossible to model. As noted in the 'SandboxAQ Helps Unlock the Next Generation of AI-Driven Chemistry' press release from July 2024, SandboxAQ's collaboration with NVIDIA achieved an 80x speedup in quantum chemistry calculations compared to traditional CPU-based methods, significantly shortening drug discovery timelines.

Additionally, the adoption of Hybrid Quantum-Classical Computing Architectures is emerging as a critical strategy to bypass the limitations of current noisy intermediate-scale quantum (NISQ) hardware. In this model, pharmaceutical companies utilize quantum processors to solve specific, computationally intensive sub-problems-such as molecular folding-while offloading remaining workloads to classical supercomputers. This approach allows organizations to derive immediate value from developing quantum systems without waiting for fully fault-tolerant machines. For instance, in the June 2024 announcement 'Moderna and IBM Demonstrate Quantum-Classical Approach for mRNA Secondary Structure Prediction,' IBM and Moderna revealed that their hybrid workflow successfully simulated mRNA secondary structures of up to 60 nucleotides using 80 qubits, a record-setting scale that demonstrates the growing utility of hybrid systems for complex therapeutic design.

Key Market Players

• IBM Corporation
• Google LLC
• Microsoft Corporation
• Intel Corporation
• Honeywell International Inc.
• D-Wave Systems Inc.
• Amazon.com, Inc.
• IonQ, Inc.
• Rigetti Computing, Inc.
• Accenture plc

Report Scope

In this report, the Global Quantum Computing in Healthcare Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Quantum Computing in Healthcare Market, By Component

• Hardware
• Software
• Services

Quantum Computing in Healthcare Market, By Technology

• Superconducting Qubits
• Trapped Ions
• Quantum Annealing
• Others

Quantum Computing in Healthcare Market, By Application

• Drug Discovery & Development
• Medical Diagnostics
• Genomics & Precision Medicine
• Radiotherapy
• Risk Analysis
• Others

Quantum Computing in Healthcare Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Quantum Computing in Healthcare Market.

Available Customizations:

Global Quantum Computing in Healthcare Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).